Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Oct, 19 2025
Jan, 9 2026
Dec, 22 2025
Sep, 29 2025
Mar, 19 2025